Injective Coin (INJ) continues to make substantial strides within the crypto market. With promises of faster and cheaper DeFi,
native USDC support,
cross-chain transfers, and the
launch of a native EVM, it is positioning itself as a significant player in the sector. Further, its price predictions are positive, with several analysts suggesting it could surpass
$50 by 2030. That being said, while the coin's recent activities seem positive, the coin has seen some volatility, with drops of 3.9% being followed by significant recoveries and jumps in price. There were also plans to
slash INJ's token supply to help boost deflation, a move that received overwhelming support from the community. Partnerships are on the horizon, the most notable of which is with
Korea University Blockchain Institute as a validator. There has also been the move by Pineapple Financial to migrate its $10B Mortgage portfolio onchain via Injective. Further, the
Canary Capital has filed for an INJ ETF, showing growing altcoin fund demand, and
Injective community approved a supply squeeze Tokenomics Shift, an interesting development in its attempts to maintain its value. These moves signal not only the currency's growth but its continuous innovation within the finance sector.
Injective Coin News Analytics from Thu, 03 Mar 2022 03:34:04 GMT to Tue, 24 Mar 2026 19:51:00 GMT -
Rating 7
- Information 5
- Rumor 9
